Freudenberg Medical launches new hemostasis valves


valves catheters Freudenberg MedicalFreudenberg Medical has launched several new hemostasis valves for interventional and diagnostic catheters.

HyperSeal and CertuSeal hemostasis valves have been added to the FlexSeal valve line that the company released last year. Freudenberg Medical also added its new HyperSeal Introducer Sheath with Hydrophilic Coating to the FlexSeal Introducer Sheath for large bore procedures.

The catheters were introduced at the Transcatheter Cardiovascular Therapeutics Conference (TCT) in Denver this year.

“Freudenberg Medical’s hemostasis valves provide a wide range of innovative features designed to greatly improve hemostasis and procedural performance when integrated into next-generation catheters and delivery systems,” Bernie Kaeferlein, director of portfolio management at Freudenberg Medical. “As a partner for innovation, we are committed to proactively addressing unmet clinical needs and offering our medical device customers a growing portfolio of finished device, design and process solutions to help improve efficiency and accelerate their time to market.”

(Network with Freudenberg Medical experts at DeviceTalks West, Dec. 11–12 in Orange County, Calif.) 

How do you know your technology is disruptive enough to break conventional wisdom?

textadimage Stan Rowe knows a little something about bringing disruptive technology to market. The current Edwards Lifesciences CSO was in on the ground floor of two of medtech's most disruptive treatments, stents and transcatheter aortic valve replacement.

On December 12th, Rowe will sit down with MassDevice editor Brad Perriello for a long ranging discussion about the inside story on how these technologies came to market and what Rowe learned along the way.

Register now with the code "TAVR" and save 15% today.

Speak Your Mind